Presentations hosted by exhibitors and/or non-exhibitors in two Presentation Theaters located in the exhibit hall during exhibit hours. Companies will showcase new products and/or treatment options during the Annual Convention and Scientific Assembly. Presentation theaters will feature non-CME presentations/speakers with round-table dining for each theater.
Monday, July 31
PrEP today. Data discussions on an HIV-1 PrEP option.
Theater #1 – 11:30 AM – 12:30 PM
During this educational session, attendees will learn about an alternative PrEP option to help prevent HIV in their patients. The program will review important information, clinical data, and dosing and administration, and provide guidance on identifying patients who would benefit.
Speakers: Zandraetta Tims-Cook, M.D., M.P.H., Faebris Medical; Toyin Nwafor, M.D., ViiV Healthcare Medical Presenter; PrEP Ambassador: Ashley
Supported by: ViiV Healthcare
Learn how to suspect, diagnose, and treat ATTR-cardiac amyloidosis, an under-recognized cause of heart failure in your Black/African American and Afro-Caribbean patients
Theater #2 – 12:00 PM – 1:00 PM
ATTR-CM is a serious, under-recognized, under-diagnosed cause of heart failure. Join us to help raise awareness of signs & symptoms of hereditary ATTR-CM, particularly in Black/African American/Afro-Caribbean patients. The program will also review clinical data for an approved treatment option for ATTR-CM.
Supported by: Pfizer Inc.
REAL TALK: MASTERING THE ART OF CONVERSATION WITH PATIENTS ON SEXUAL HEALTH AND HIV
Theater #1 – 1:30 PM – 2:30 PM
This program will highlight the important role of physicians in having honest dialogue with patients about sexual health and HIV, ultimately to support increased awareness of HIV testing and prevention. It will feature roleplays and interactive activities to illustrate the art of conversation.
Speaker: Theo Hodge, M.D., Medical Director, Washington Health Institute, Washington, DC
Panelists: Yolanda Lawson, MD, FACOG, President-Elect, National Medical Association, Silver Spring, MD, Founder, MadeWell OBGYN, Dallas, TX , Associate Attending, Baylor University Medical Center, Dallas, TX; Michael G. Knight, M.D., MSHP, Clinical Associate Professor of Medicine, The George Washington University, Washington, DC
Supported by: Gilead Sciences, Inc.
Tuesday, August 1
An Unexpected Opponent: Alonzo Mourning’s Journey with APOL1-Mediated Kidney Disease (AMKD)
Theater #1 – 11:30 AM – 12:30 PM
Join us for a discussion between basketball hall-of-famer Alonzo Mourning and Dr. Ogo Egbuna, Vice President of Clinical Development at Vertex Pharmaceuticals. They’ll discuss Alonzo’s journey with AMKD and how medical professionals and patients can be proactive about genetic kidney disease.
Speakers: Alonzo Mourning, Basketball Hall-of-Famer diagnosed with AMKD; Dr. Ogo Egbun, FASN, Nephrologist & Vice President of Clinical Development,Vertex Pharmaceuticals
Supported by: Vertex Pharmaceuticals
Exploring Disease and Disparities for African Americans Living With Multiple Myeloma
Theater #2 – 12:00 PM – 1:00 PM
This program shines a spotlight on racial disparities in the diagnosis and outcomes of multiple myeloma. Those who attend this program can expect to gain insight into factors that may be responsible for these disparities and will be presented with several approaches that may help address them.
Speaker: Edith Mitchell, M.D.
Supported by: Bristol Myers Squibb
Beyond the Rash: Examining the Burden of Herpes Zoster in Populations at Increased Risk
Theater #1 – 1:30 PM – 2:30 PM
An increased risk of herpes zoster has been traditionally linked to patients 50 years and older. However, did you know the risk is also increased in other populations? We invite you to join us for an engaging discussion where we review the burden of herpes zoster in populations at increased risk.
Speakers: Nnanya Kalu M.D., Ph.D., Director, Medical Affairs, GSK; Nikita Stempniewicz, M.Sc., Director, US Health Outcomes & Epidemiology, GSK US Medical Affairs Vaccines Health Outcomes
Supported by: GSK